Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients
Clinical trial NCT02666430 · COMPLETED
Trial details
- NCT number
- NCT02666430
- Sponsor
- Mylan Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-03-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.